Role of lipopolysaccharide in the induction of type I interferon-dependent cross-priming and IL-10 production in mice by meningococcal outer membrane vesicles

Vaccine

Volumn 27, Issue 13, 2009, Pages 1912-1922

  Durand, Vanessa ^a   MacKenzie, Joanne ^a   de Leon, Joel ^b   Mesa, Circe ^b   Quesniaux, Valérie ^c   Montoya, Maria ^a   Le Bon, Agnes ^a   Wong, Simon Y C ^a  

^a EDWARD JENNER INST FOR VACC RES   (United Kingdom)

^b CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^c UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

Cross priming; Lipopolysaccharide; Meningococcal disease

Indexed keywords

GAMMA INTERFERON; INTERFERON; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CROSS PRESENTATION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; LYMPHOCYTE PROLIFERATION; MALE; MEMBRANE VESICLE; MENINGOCOCCOSIS; MOUSE; NATIVE OUTER MEMBRANE VESICLE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; B-LYMPHOCYTES; BACTERIAL OUTER MEMBRANE PROTEINS; BONE MARROW CELLS; CELL MEMBRANE; CELL PROLIFERATION; CROSS-PRIMING; CYTOKINES; DENDRITIC CELLS; FEMALE; INTERFERON TYPE I; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MALE; MENINGITIS, MENINGOCOCCAL; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NITRIC OXIDE; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 61349186919     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.109     Document Type: Article

References (58)

1. Tzeng Y.L., and Stephens D.S. Epidemiology and pathogenesis of Neisseria meningitidis. Microbes Infect 2 (2000) 687-700
2. Wyle F.A., Artenstein M.S., Brandt B.L., Tramont E.C., Kasper D.L., Altieri P.L., et al. Immunologic response of man to group B meningococcal polysaccharide vaccines. J Infect Dis 26 (1972) 514-521
3. Borrow R., Balmer P., and Miller E. Meningococcal surrogates of protection-serum bactericidal antibody activity. Vaccine 23 (2005) 2222-2227
4. Andersen S.R., Bjune G., Høiby E.A., Michaelsen T.E., Aase A., Rye U., et al. Outer membrane vesicle vaccines made from short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis: effect of the carbohydrate chain length on the immune response. Vaccine 15 (1997) 1225-1234
5. Fredriksen J.H., Rosenqvist E., Wedege E., Bryn K., Bjune G., Frøholm L.O., et al. Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann 14 (1991) 67-80
6. Aase A., Naess L.M., Sandin R.H., Herstad T.K., Oftung F., Holst J., et al. Comparison of functional immune responses in humans after intranasal and intramuscular immunisations with outer membrane vesicle vaccines against group B meningococcal disease. Vaccine 21 (2003) 2042-2051
7. Katial R.K., Brandt B.L., Moran E.E., Marks S., Agnello V., and Zollinger W.D. Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine. Infect Immun 70 (2002) 702-707
8. Goldschneider I., Gotschlich E.C., and Artenstein M.S. Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med 129 (1969) 1327-1348
9. Pollard A.J., and Frasch C. Development of natural immunity to Neisseria meningitidis. Vaccine 19 (2001) 1327-1346
10. Robinson K., Neal K.R., Howard C., Stockton J., Atkinson K., Scarth E., et al. Characterization of humoral and cellular immune responses elicited by meningococcal carriage. Infect Immun 70 (2002) 1301-1309
11. Oliver K.J., Reddin K.M., Bracegirdle P., Hudson M.J., Borrow R., Feavers I.M., et al. Neisseria lactamica protects against experimental meningococcal infection. Infect Immun 70 (2002) 3621-3626
12. Goldschneider I., Gotschlich E.C., and Artenstein M.S. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 129 (1969) 1307-1326
13. Oftung F., Naess L.M., Wetzler L.M., Korsvold G.E., Aase A., Høiby E.A., et al. Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccine. Infect Immun 67 (1999) 921-927
14. Davenport V., Guthrie T., Findlow J., Borrow R., Williams N.A., and Heyderman R.S. Evidence for naturally acquired T cell-mediated mucosal immunity to Neisseria meningitidis. J Immunol 171 (2003) 4263-4270
15. Davenport V., Groves E., Hobbs C.G., Williams N.A., and Heyderman R.S. Regulation of Th-1 T cell-dominated immunity to Neisseria meningitidis within the human mucosa. Cell Microbiol 9 (2007) 1050-1061
16. Guthrie T., Wong S.Y., Liang B., Hyland L., Hou S., Høiby E.A., et al. Local and systemic antibody responses in mice immunized intranasally with native and detergent-extracted outer membrane vesicles from Neisseria meningitidis. Infect Immun 72 (2004) 2528-2537
17. Saunders N.B., Shoemaker D.R., Brandt B.L., Moran E.E., Larsen T., and Zollinger W.D. Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice. Infect Immun 67 (1999) 113-119
18. Drabick J.J., Brandt B.L., Moran E.E., Saunders N.B., Shoemaker D.R., and Zollinger W.D. Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers. Vaccine 18 (1999) 160-172
19. Quesniaux V.J., Nicolle D.M., Torres D., Kremer L., Guérardel Y., Nigou J., et al. Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J Immunol 172 (2004) 4425-4434
20. Andersen S.R., Bjune G., Lyngby J., Bryn K., and Jantzen E. Short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis of potential value for production of outer membrane vesicle vaccines. Microb Pathog 19 (1995) 159-168
21. Steeghs L., den Hartog R., den Boer A., Zomer B., Roholl P., and van der Ley P. Meningitis bacterium is viable without endotoxin. Nature 392 (1998) 449-450
22. Andersen S.R., Guthrie T., Guile G.R., Kolberg J., Hou S., Hyland, et al. Cross-reactive polyclonal antibodies to the inner core of lipopolysaccharide from Neisseria meningitidis. Infect Immun 70 (2002) 1293-1300
23. Steeghs L., de Cock H., Evers E., Zomer B., Tommassen J., and van der Ley P. Outer membrane composition of a lipopolysaccharide-deficient Neisseria meningitidis mutant. EMBO J 20 (2001) 6937-6945
24. Durand V., Wong S.Y., Tough D.F., and Le Bon A. Shaping of adaptive immune responses to soluble proteins by TLR agonists: a role for IFN-alpha/beta. Immunol Cell Biol 82 (2004) 596-602
25. Lutz M.B., Kukutsch N., Ogilvie A.L., Rössner S., Koch F., Romani N., et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223 (1999) 77-92
26. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176 (1992) 1693-1702
27. Montoya M., Schiavoni G., Mattei F., Gresser I., Belardelli F., Borrow P., et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99 (2002) 3263-3271
28. Aichele P., Brduscha-Riem K., Oehen S., Odermatt B., Zinkernagel R.M., Hengartner H., et al. Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology. Immunity 6 (1997) 519-529
29. Oehen S., and Brduscha-Riem K. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J Immunol 161 (1998) 5338-5346
30. Le Bon A., Etchart N., Rossmann C., Ashton M., Hou S., Gewert D., et al. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol 4 (2003) 1009-1015
31. Brandtzaeg P., Kierulf P., Gaustad P., Skulberg A., Bruun J.N., Halvorsen S., et al. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 159 (1989) 195-204
32. Brandtzaeg P., Bjerre A., Øvstebø R., Brusletto B., Joø G.B., and Kierulf P. Neisseria meningitidis lipopolysaccharides in human pathology. J Endotoxin Res 7 (2001) 401-420
33. Liu M.A., Friedman A., Oliff A.I., Tai J., Martinez D., Deck R.R., et al. A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes. Proc Natl Acad Sci 89 (1992) 4633-4637
34. Mandrell R.E., Griffiss J.M., and Macher B.A. Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that recognize crossreacting antigens on LOS and human erythrocytes. J Exp Med 168 (1988) 107-126
35. Raetz C.R.H., and Whitfield C. Lipopolysaccharide endotoxins. Ann Rev Biochem 71 (2002) 635-700
36. Donnelly J.J., Deck R.R., and Liu M.A. Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine. J Immunol 145 (1990) 3071-3079
37. Wetzler L.M., Ho Y., and Reiser H. Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate. J Exp Med 183 (1996) 1151-1159
38. Massari P., Henneke P., Ho Y., Latz E., Golenbock D.T., and Wetzler L.M. Cutting edge: immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent. J Immunol 168 (2002) 1533-1537
39. Singleton T.E., Massari P., and Wetzler L.M. Neisserial porin-induced dendritic cell activation is MyD88 and TLR2 dependent. J Immunol 174 (2005) 3545-3550
40. O'Neill L.A., and Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7 (2007) 353-364
41. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683-765
42. Kishimoto T. Interleukin-6: from basic science to medicine-40 years in immunology. Annu Rev Immunol 23 (2005) 1-21
43. Bevan M.J. Immunology. Stimulating killer cells. Nature 342 (1989) 478-479
44. Sigal L.J., Crotty S., Andino R., and Rock K.L. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398 (1999) 77-80
45. Heath W.R., and Carbone F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 19 (2001) 47-64
46. Schwarz K., Storni T., Manolova V., Didierlaurent A., Sirard J.C., Röthlisberger P., et al. Role of Toll-like receptors in costimulating cytotoxic T cell responses. Eur J Immunol 33 (2003) 1465-1470
47. + T cell expansion with variable dependence on type I IFN. J Exp Med 199 (2004) 775-784
48. Mesa C., de León J., and Fernández L.E. Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for generation of CTL responses to peptide and protein antigens. Vaccine 24 (2006) 2692-2699
49. Gessani S., Belardelli F., Borghi P., Boraschi D., and Gresser I. Correlation between the lipopolysaccharide response of mice and the capacity of mouse peritoneal cells to transfer an antiviral state. Role of endogenous interferon. J Immunol 139 (1987) 1991-1998
50. Post D.M., Zhang D., Eastvold J.S., Teghanemt A., Gibson B.W., and Weiss J.P. Biochemical and functional characterization of membrane blebs purified from Neisseria meningitidis serogroup B. J Biol Chem 280 (2005) 38383-38394
51. Higgins S.C., Lavelle E.C., McCann C., Keogh B., McNeela E., Byrne P., et al. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J Immunol 171 (2003) 3119-3127
52. Fujita S., Seino K., Sato K., Sato Y., Eizumi K., Yamashita N., et al. Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response. Blood 107 (2006) 3656-3664
53. Roncarolo M.G., Gregori S., Battaglia M., Bacchetta R., Fleischhauer K., and Levings M.K. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212 (2006) 28-50
54. Levings M.K., Sangregorio R., Galbiati F., Squadrone S., de Waal Malefyt R., and Roncarolo M.G. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 166 (2001) 5530-5539
55. Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67 (2003) 593-656
56. Etchart N., Baaten B., Andersen S.R., Hyland L., Wong S.Y., and Hou S. Intranasal immunisation with inactivated RSV and bacterial adjuvants induces mucosal protection and abrogates eosinophilia upon challenge. Eur J Immunol 36 (2006) 1136-1144
57. Fisseha M., Chen P., Brandt B., Kijek T., Moran E., and Zollinger W. Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination. Infect Immun 73 (2005) 4070-4080
58. Steeghs L., Keestra A.M., van Mourik A., Uronen-Hansson H., van der Ley P., Callard R., et al. Differential activation of human and mouse Toll-like receptor 4 by the adjuvant candidate LpxL1 of Neisseria meningitidis. Infect Immun 76 (2008) 3801-3807